Diabetes and cardiovascular disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Diabetes in America, edn 2. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Diabetes Data Group; 1995.
Howard BV, Magee MF: Macrovascular complications of diabetes mellitus. In Diabetes Mellitus, edn 2. Edited by LeRoith D, Taylor SI, Olefsky JM. Philadelphia: Lippincott-Raven, 2000:957–962.
Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–234.
Sievers ML, Fisher JR: Diseases of North American Indians. In Biocultural Aspects of Disease. Edited by Rothschild HR. New York: Academic Press; 1981:191–252.
Howard BV, Lee ET, Cowan LD, et al.: Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart Study. Am J Epidemiol 1995, 142:254–268.
Indian Health Service: IHS Chart Series Book, June 1984. Washington DC, U.S. Government Printing Office, US Dept. of Health & Human Services; 1984.
US Congress: Office of Technology Assessment. Indian Health Care. OTA-H-290. Washington, DC: US Government Printing Office; April, 1986.
Lee ET, Cowan LD, Welty TK, et al.: All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years, 1984–1988: The Strong Heart Study. Am J Epidemiol, 1998, 147:995–1008.
Howard BV, Lee ET, Cowan LD, et al.: Rising tide of cardiovascular disease in American Indians: the Strong Heart study. Circulation 1999, 99:2389–2395.
Chambless LE, Heiss G, Folsom AR, et al.: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987 to 1993. Am J Epidemiol 1997, 146:483–494.
Howard BV, Cowan LD, Go O, et al.: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. Diabetes Care 1998, 21:1258–1265.
Howard BV, Lee ET, Cowan LD, et al.: LDL cholesterol is a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart study. Atheroscler Thromb Vasc Biol 2000, 20:830–835.
Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434–444.
Haffner SM, Cassells HB: Type 2 diabetes and coronary heart disease. Role of dyslipidemia and insulin resistance. Practical Diabetology 1998:6–9.
Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 1987, 294:1651–1654.
Parving HH, Gall MA, Neilson FS: Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patients with and without diabetic nephropathy. J Intern Med 1994, 736:89–94.
Savage S, Estacio RO, Jeffers B, Schrier RW: Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996, 19:1243–1248.
Rahmaniyan M, Robbins DC, Roman MJ: Albuminuria (UA) is independently associated with larger left ventricular (LV) mass in NIDDM: the Strong Heart Study (SHS). Diabetes 1998, 47:A9.
McCarty MF: Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999, 52:465–477.
Duh E, Aiello LP: Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox. Diabetes 1999, 48:1899–1906.
de Luis DA, Lahera M, Canton R, et al.: Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998, 21:1129–1132.
Kenny SJ, Aubert RF, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America, edn 2. Edited by Harris MI, Cowie CC, Stern MP, et al. Washington, DC: US Government Printing Office; 1995:47–68 (NIH Publ. No. 95-1468).
Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 1987, 36:523–534.
Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2:120–126.
Kannel WB, Wilson PWF: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995, 155:57–61.
Heyden S, Heiss G, Bartel AG, Hames CG: Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 1980, 33:265–273.
Pan WH, Cedres LB, Liu K, et al.: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986, 123:504–516.
Elveback LR, Connolly DC, Melton LJ: Coronary heart disease in residents of Rochester, Minnesota: incidence, 1950 through 1982. Mayo Clin Proc 1986, 61:896–900.
DeStefano F, Ford ES, Newman J, et al.: Risk factors of coronary heart disease mortality among persons with diabetes. Ann Epidemiol 1993, 3:27–34.
Sprafka JM, Pankow J, McGovern PG, French LR: Mortality among type 2 diabetic individuals and associated risk factors: the Three City study. Diabet Med 1993, 10:627–632.
Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? the Rancho Bernardo study. JAMA 1991, 265:627–631.
Rewers M, Shetterly SM, Baxter J, et al.: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes study. Am J Epidemiol 1992, 135:1321–1330.
Matthews KA, Meilahn E, Kuller LH, et al.: Menopause and risk factors for coronary heart disease. N Engl J Med 1989, 321:641–646.
Wahl PW, Walden CE, Knopp RH, et al.: Lipid and lipoprotein triglyceride and cholesterol interrelationships: effects of sex, hormone use, and hyperlipidemia. Metabolism 1984, 33:502–508.
Knopp RH, Zhu X, Bonet B: Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 1995, 110:S83-S91.